Search for: "ORTHO-MCNEIL PHARMACEUTICAL INC"
Results 61 - 80
of 184
Sorted by Relevance
|
Sort by Date
13 Aug 2015, 10:56 am
Ortho-McNeil Pharmaceuticals, Inc., another Ortho-Evra case, the district court held that preemption is not restricted to only generic drugs, rather “[t]he Supreme Court specifically stated that ‘once a drug – whether generic or brand-name – is approved, the manufacturer is prohibited from making any major changes to the qualitative or quantitative formulation of the drug product, including active ingredients, or in the… [read post]
28 May 2010, 9:30 am
May 10, 2010) (80 PTCJ 56, 5/14/10), and Ortho-McNeil Pharmaceutical Inc. v. [read post]
5 Jul 2011, 11:13 pm
One of J&J's lawyers said, “The jury took a good, hard look at all the evidence and correctly concluded that Ortho-McNeil-Janssen Pharmaceuticals, Inc. acted responsibly and properly in disclosing the risks associated with this effective and life-saving medicine. [read post]
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
7 Oct 2010, 12:35 pm
Ortho McNeil Pharmaceutical, Inc introduced the Ortho Evra birth control patch in 2002. [read post]
3 Sep 2009, 1:13 am
Defendants Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development are denying that Levaquin is defective or unreasonably dangerous. [read post]
4 Sep 2009, 12:11 pm
Noting Ortho-McNeil Pharm., Inc. v. [read post]
21 Apr 2009, 8:45 am
Ortho-McNeil, Inc., No. [read post]
10 May 2010, 10:37 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
18 Apr 2011, 12:40 pm
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects… [read post]
6 Oct 2009, 10:44 am
Between November 1997 and December 2005, the FDA received 262 reported cases of tendon ruptures, 258 cases of tendonitis, and 274 cases of other tendon disorders associated with the drug sold by Ortho-McNeil Pharmaceutical, Inc. [read post]
17 Dec 2015, 5:50 pm
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
21 Jun 2015, 6:17 pm
Johnson & Johnson Services, Inc. et al El Sr. [read post]
15 Jul 2010, 10:39 pm
Texas resident Kenneth Edward Adams has filed the newest lawsuit against Levaquin makers Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development as of June 29 of 2010. [read post]
12 Feb 2008, 2:55 pm
PriCara is a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
31 Mar 2016, 3:00 am
Ortho-McNeil Pharm., Inc., 808 F.3d 281 (6th Cir 2015). [read post]
